tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SONN Stock Latest News

Sonnet BioTherapeutics Advances Solid Tumor Trial
Company AnnouncementsSonnet BioTherapeutics Advances Solid Tumor Trial
3m ago
8K
SONN
Sonnet BioTherapeutics completes enrollment in Phase 1 study of SON-1010
PremiumThe Fly
Sonnet BioTherapeutics completes enrollment in Phase 1 study of SON-1010
20m ago
SONN
Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
PremiumPress Releases
Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
25m ago
SONN
Sonnet BioTherapeutics to Present at Investor Series
PremiumCompany Announcements
Sonnet BioTherapeutics to Present at Investor Series
9d ago
8K
SONN
Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series
PremiumPress Releases
Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series
14d ago
SONN
Sonnet BioTherapeutics Advances Pancreatic Cancer Drug Trial
PremiumCompany AnnouncementsSonnet BioTherapeutics Advances Pancreatic Cancer Drug Trial
30d ago
8K
SONN
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
Premium
Press Releases
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
1M ago
SONN
Sonnet enters into collaboration agreement with Sarcoma Oncology Center
Premium
The Fly
Sonnet enters into collaboration agreement with Sarcoma Oncology Center
1M ago
SONN
Sonnet BioTherapeutics reports Q3 EPS (70c) vs. ($2.95) last year
PremiumThe Fly
Sonnet BioTherapeutics reports Q3 EPS (70c) vs. ($2.95) last year
1M ago
SONN
Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
1M ago
SONN
SONN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SONN Earnings this Week: How Will it Perform?
1M ago
SONN
Sonnet BioTherapeutics Advances SON-080 into Phase 2 Trials
PremiumCompany Announcements
Sonnet BioTherapeutics Advances SON-080 into Phase 2 Trials
2M ago
8K
SONN
Sonnet BioTherapeutics reports data from Phase 1b/2a trial of SON-080
PremiumThe FlySonnet BioTherapeutics reports data from Phase 1b/2a trial of SON-080
2M ago
SONN
Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
Premium
Press Releases
Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
2M ago
SONN
Sonnet BioTherapeutics files to sell 5.77M shares of common stock for holders
Premium
The Fly
Sonnet BioTherapeutics files to sell 5.77M shares of common stock for holders
2M ago
SONN
Sonnet BioTherapeutics announces exercise of warrants for $3.4M in proceeds
PremiumThe Fly
Sonnet BioTherapeutics announces exercise of warrants for $3.4M in proceeds
3M ago
SONN
Sonnet BioTherapeutics Unveils Innovative Immunotherapeutic Candidates
PremiumCompany Announcements
Sonnet BioTherapeutics Unveils Innovative Immunotherapeutic Candidates
3M ago
8K
SONN
Sonnet BioTherapeutics announces generation of two drug candidates
PremiumThe Fly
Sonnet BioTherapeutics announces generation of two drug candidates
3M ago
SONN
Sonnet BioTherapeutics to present SB221 as trial in progress at ASCO 2024
PremiumThe Fly
Sonnet BioTherapeutics to present SB221 as trial in progress at ASCO 2024
4M ago
SONN
Sonnet BioTherapeutics announces review of strategic alternatives
PremiumThe FlySonnet BioTherapeutics announces review of strategic alternatives
4M ago
SONN
Sonnet BioTherapeutics announces updated clinical data for SON-1010
Premium
The Fly
Sonnet BioTherapeutics announces updated clinical data for SON-1010
4M ago
SONN
Sonnet BioTherapeutics price target lowered to $7 from $11 at EF Hutton
Premium
The Fly
Sonnet BioTherapeutics price target lowered to $7 from $11 at EF Hutton
4M ago
SONN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >